- Home
- OSUR vs BCYC Comparison
OSUR vs BCYC Comparison
Compare OSUR & BCYC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | OSUR | BCYC |
|---|---|---|
| Founded | 2000 | 2009 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 295.7M | 291.8M |
| IPO Year | 2000 | 2019 |
Fundamental Metrics
Financial Performance| Metric | OSUR | BCYC |
|---|---|---|
| Price | $4.00 | $3.98 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 2 | 10 |
| Target Price | $3.00 | ★ $13.90 |
| AVG Volume (30 Days) | ★ 397.4K | 284.3K |
| Earning Date | 05-06-2026 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $167,064,000.00 | N/A |
| Revenue This Year | $4.48 | N/A |
| Revenue Next Year | $7.76 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.08 | $3.75 |
| 52 Week High | $4.58 | $9.16 |
Technical Indicators
Market Signals| Indicator | OSUR | BCYC |
|---|---|---|
| Relative Strength Index (RSI) | 49.05 | 46.11 |
| Support Level | $3.89 | $3.94 |
| Resistance Level | $4.29 | $4.52 |
| Average True Range (ATR) | 0.18 | 0.14 |
| MACD | -0.01 | 0.02 |
| Stochastic Oscillator | 57.27 | 55.91 |
Price Performance
Historical ComparisonAbout OSUR OraSure Technologies Inc.
OraSure Technologies Inc is principally engaged in the development, manufacture, marketing, sale and distribution of (i) diagnostics products, and (ii) sample management solutions. It develops products and services that support diagnostic testing and healthcare data analysis, with a focus on improving access to healthcare. The company derives its revenues from the sale of diagnostics products and sample management solutions. Geographically, it generates the maximum revenue from the United States.
About BCYC Bicycle Therapeutics plc
Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops that stabilize their structural geometry. Its initial internal programs are focused on oncology indications with high unmet medical needs. The company's product candidate, BT1718, is a Bicycle Toxin Conjugate, or BTC. The company has two segments: the United Kingdom and the United States. It derives maximum revenue from United Kingdom.